Skip to main content
Top
Published in: BMC Infectious Diseases 1/2018

Open Access 01-12-2018 | Research article

Risk factors associated with multidrug-resistant tuberculosis (MDR-TB) in a tertiary armed force referral and teaching hospital, Ethiopia

Authors: Biresaw Demile, Amare Zenebu, Haile Shewaye, Siqing Xia, Awoke Guadie

Published in: BMC Infectious Diseases | Issue 1/2018

Login to get access

Abstract

Background

Ethiopia is one of the world health organization defined higher tuberculosis (TB) burden countries where the disease remains a massive public health threat. This study aimed to identify the prevalence and associated factors of multidrug-resistant tuberculosis (MDR-TB) using all armed force and civilian TB attendants in a tertiary level armed force hospital, where data for MDR-TB are previously unpublished.

Methods

Cross-sectional study was conducted from September 2014 to August 2015 in a tertiary level Armed Force Referral and Teaching Hospital (AFRTH), Ethiopia. Armed force members (n = 251) and civilians (n = 130) which has been undergone TB diagnosis at AFRTH were included. All the specimens collected were subjected to microscopic smear observation, culture growth and drug susceptibility testing. Data were analyzed using statistical package for social sciences following binary logistic regression and Chi-square. P-values < 0.05 were considered statistically significant.

Results

Among 381 TB patients, 355 (93.2%) new and 26 (6.8%) retreatment cases were identified. Culture and smear positive TB cases were identified in 297 (77.9%) and 252 (66.1%) patients, respectively. The overall prevalence of MDR-TB in AFRTH was found 1.8% (1.3% for armed force members and 0.5% for civilian patients) all of which were previously TB treated cases. The entire treatment success rates were 92.6% achieved highest in the armed force (active and pension) than the civilian patients. The failure and dead cases were also found 2.5 and 4.6%, respectively. Using bivariate analysis, category of attendants and TB contact history were strong predictors of MDR-TB in armed force and civilian patients. Moreover, human immunodeficiency virus (HIV) infection also identified a significant (OR = 14.6; 95% CI = 2.3–92.1; p = 0.004) predicting factor for MDR-TB in armed force members. However, sex, age and body mass index were not associated factor for MDR-TB.

Conclusions

In AFRTH, lower prevalence of MDR-TB was identified in armed force and civilian patients that were significantly associated with category of attendants, HIV infection and TB contact history. Considering armed force society as one segment of population significantly helps to plan a better MDR-TB control management, especially for countries classified as TB high burden country.
Literature
1.
go back to reference World Health Organization. Global tuberculosis report. Geneva: World Health; 2017. World Health Organization. Global tuberculosis report. Geneva: World Health; 2017.
2.
go back to reference Sanchez JL, Sanchez JL, Cooper MJ, Hiser MJ, Mancuso JD. Tuberculosis as a force health protection threat to the United States military. A review Mil Med. 2015;180:276–84.CrossRef Sanchez JL, Sanchez JL, Cooper MJ, Hiser MJ, Mancuso JD. Tuberculosis as a force health protection threat to the United States military. A review Mil Med. 2015;180:276–84.CrossRef
4.
go back to reference Workneh MH, Bjune GA, Yimer SA. Diabetes mellitus is associated with increased mortality during tuberculosis treatment: a prospective cohort study among tuberculosis patients in south-eastern Amahra region, Ethiopia. Infect Dis Poverty. 2016;5:22.CrossRefPubMedPubMedCentral Workneh MH, Bjune GA, Yimer SA. Diabetes mellitus is associated with increased mortality during tuberculosis treatment: a prospective cohort study among tuberculosis patients in south-eastern Amahra region, Ethiopia. Infect Dis Poverty. 2016;5:22.CrossRefPubMedPubMedCentral
5.
go back to reference World Health Organization. Global tuberculosis control report. 20th ed. Geneva: World Health Organization; 2015. World Health Organization. Global tuberculosis control report. 20th ed. Geneva: World Health Organization; 2015.
6.
go back to reference Nachega JB, Chaisson RE. Tuberculosis drug resistance: a global threat. Clin Infect Dis. 2003;36:24–30.CrossRef Nachega JB, Chaisson RE. Tuberculosis drug resistance: a global threat. Clin Infect Dis. 2003;36:24–30.CrossRef
7.
go back to reference Federal Ministry of Health (FMOH), Ministry of Health of Ethiopia. Tuberculosis, leprosy and TB/HIV Prevention and Control program manual. 4th ed. Addis Ababa: Federal Ministry of Health; 2008. Federal Ministry of Health (FMOH), Ministry of Health of Ethiopia. Tuberculosis, leprosy and TB/HIV Prevention and Control program manual. 4th ed. Addis Ababa: Federal Ministry of Health; 2008.
8.
go back to reference Lee SW, Jeon K, Kim KH, Min KH. Multidrug-resistant pulmonary tuberculosis among young Korean soldiers in a communal setting. J Korean Med Sci. 2009;24:592–5.CrossRefPubMedPubMedCentral Lee SW, Jeon K, Kim KH, Min KH. Multidrug-resistant pulmonary tuberculosis among young Korean soldiers in a communal setting. J Korean Med Sci. 2009;24:592–5.CrossRefPubMedPubMedCentral
9.
go back to reference Campodónico VL, Rifat D, Chuang YM, Loerger TR, Karakousis PC. Altered Mycobacterium tuberculosis cell wall metabolism and physiology associated with RpoB mutation H526D. Front Microbiol. 2018;9:494.CrossRefPubMedPubMedCentral Campodónico VL, Rifat D, Chuang YM, Loerger TR, Karakousis PC. Altered Mycobacterium tuberculosis cell wall metabolism and physiology associated with RpoB mutation H526D. Front Microbiol. 2018;9:494.CrossRefPubMedPubMedCentral
10.
go back to reference Yuan Y, Zhu Y, Crane DD, Barry CE. The effect of oxygenated mycolic acid composition on cell wall function and macrophage growth in Mycobacterium tuberculosis. Mol Microbiol. 1998;29:1449–58.CrossRefPubMed Yuan Y, Zhu Y, Crane DD, Barry CE. The effect of oxygenated mycolic acid composition on cell wall function and macrophage growth in Mycobacterium tuberculosis. Mol Microbiol. 1998;29:1449–58.CrossRefPubMed
11.
go back to reference Pal R, Fatima Z, Hameed S. Efflux pumps in drug resistance of Mycobacterium tuberculosis. Int J Curr Microbiol App Sci. 2014;3:528–46. Pal R, Fatima Z, Hameed S. Efflux pumps in drug resistance of Mycobacterium tuberculosis. Int J Curr Microbiol App Sci. 2014;3:528–46.
13.
go back to reference Chen W, Biswas T, Porter VR, Tsodikov OV, Garneau-Tsodikova S. Unusual regioversatility of acetyltransferase Eis, a cause of drug resistance in XDR-TB. Proc Natl Acad Sci U S A. 2011;108:9804–8.CrossRefPubMedPubMedCentral Chen W, Biswas T, Porter VR, Tsodikov OV, Garneau-Tsodikova S. Unusual regioversatility of acetyltransferase Eis, a cause of drug resistance in XDR-TB. Proc Natl Acad Sci U S A. 2011;108:9804–8.CrossRefPubMedPubMedCentral
14.
go back to reference Chen S, Huai P, Wang X, Zhong J, Wang X, Wang K, Wang L, Jiang S, Li J, Peng Y, Ma W. Risk factors for multidrug resistance among previously treated patients with tuberculosis in eastern China: a case–control study. Int J Infect Dis. 2013;17(12):e1116–20.CrossRefPubMed Chen S, Huai P, Wang X, Zhong J, Wang X, Wang K, Wang L, Jiang S, Li J, Peng Y, Ma W. Risk factors for multidrug resistance among previously treated patients with tuberculosis in eastern China: a case–control study. Int J Infect Dis. 2013;17(12):e1116–20.CrossRefPubMed
15.
go back to reference Li WB, Zhang YQ, Xing J, Ma ZY, Qu YH, Li XX. Factors associated with primary transmission of multidrug-resistant tuberculosis compared with healthy controls in Henan Province, China. Infect Dis Poverty. 2015;4:14.CrossRefPubMedPubMedCentral Li WB, Zhang YQ, Xing J, Ma ZY, Qu YH, Li XX. Factors associated with primary transmission of multidrug-resistant tuberculosis compared with healthy controls in Henan Province, China. Infect Dis Poverty. 2015;4:14.CrossRefPubMedPubMedCentral
16.
go back to reference Seyoum B, Demissie M, Worku A, Bekele S, Aseffa A. Prevalence and drug resistance patterns of Mycobacterium tuberculosis among new smear positive pulmonary tuberculosis patients in eastern Ethiopia. Tuberc Res Treat. 2014;2014:1–7.CrossRef Seyoum B, Demissie M, Worku A, Bekele S, Aseffa A. Prevalence and drug resistance patterns of Mycobacterium tuberculosis among new smear positive pulmonary tuberculosis patients in eastern Ethiopia. Tuberc Res Treat. 2014;2014:1–7.CrossRef
18.
go back to reference Migliori GB, Dheda K, Centis R, Mwaba P, Bates M, O ’ Grady J, Hoelscher M, Zumla A. Review of multidrug resistant and extensively drug resistant TB: global perspectives with a focus on sub-Saharan Africa. Tropical Med Int Health. 2010;15:1052–66.CrossRef Migliori GB, Dheda K, Centis R, Mwaba P, Bates M, O ’ Grady J, Hoelscher M, Zumla A. Review of multidrug resistant and extensively drug resistant TB: global perspectives with a focus on sub-Saharan Africa. Tropical Med Int Health. 2010;15:1052–66.CrossRef
19.
go back to reference Ben AY, Nemser B, Singh A, Sankin A, Schluger N. Under reported threat of multidrug-resistant tuberculosis in Africa. Emerg Infect Dis. 2008;14:1345–52.CrossRef Ben AY, Nemser B, Singh A, Sankin A, Schluger N. Under reported threat of multidrug-resistant tuberculosis in Africa. Emerg Infect Dis. 2008;14:1345–52.CrossRef
20.
go back to reference Mekonnen D, Admassu A, Mulu W, Amor A, Benito A, Gelaye W, Biadglegne F, Abera B. Multidrug-resistant and heteroresistant Mycobacterium tuberculosis and associated gene mutations in Ethiopia. Int J Infect Dis. 2015;39:34–8.CrossRefPubMed Mekonnen D, Admassu A, Mulu W, Amor A, Benito A, Gelaye W, Biadglegne F, Abera B. Multidrug-resistant and heteroresistant Mycobacterium tuberculosis and associated gene mutations in Ethiopia. Int J Infect Dis. 2015;39:34–8.CrossRefPubMed
21.
go back to reference Mekonnen F, Tessema B, Moges F, Gelaw A, Eshetie S, Kumera G. Multidrug resistant tuberculosis: prevalence and risk factors in districts of metema and west armachiho, Northwest Ethiopia. BMC Infect Dis. 2015;15:1–6.CrossRef Mekonnen F, Tessema B, Moges F, Gelaw A, Eshetie S, Kumera G. Multidrug resistant tuberculosis: prevalence and risk factors in districts of metema and west armachiho, Northwest Ethiopia. BMC Infect Dis. 2015;15:1–6.CrossRef
22.
go back to reference Mulisa G, Workneh T, Hordofa N, Suaudi M, Abebe G, Jarso G. Multidrug-resistant Mycobacterium tuberculosis and associated risk factors in Oromia region of Ethiopia. Int J Infect Dis. 2015;39:57–61.CrossRefPubMed Mulisa G, Workneh T, Hordofa N, Suaudi M, Abebe G, Jarso G. Multidrug-resistant Mycobacterium tuberculosis and associated risk factors in Oromia region of Ethiopia. Int J Infect Dis. 2015;39:57–61.CrossRefPubMed
23.
go back to reference World Health Organization. Guidelines for surveillance of drug resistance in tuberculosis. 4th ed. Geneva: World Health Organization; 2009. World Health Organization. Guidelines for surveillance of drug resistance in tuberculosis. 4th ed. Geneva: World Health Organization; 2009.
24.
go back to reference Kent PI, Kubica GP. Public health mycobacteriology: a guide for the level III laboratory. Atlanta: Center for disease control; 1985. Kent PI, Kubica GP. Public health mycobacteriology: a guide for the level III laboratory. Atlanta: Center for disease control; 1985.
25.
go back to reference Wang K, Chen S, Wang X, Zhong J, Wang X, Huai P, Wu L, Wang L, Jiang S, Li J, Peng Y, Yao H, Ma W. Factors contributing to the high prevalence of multidrug-resistant tuberculosis among previously treated patients: a case–control study from China. Microb Drug Resist. 2014;20:294–300.CrossRefPubMed Wang K, Chen S, Wang X, Zhong J, Wang X, Huai P, Wu L, Wang L, Jiang S, Li J, Peng Y, Yao H, Ma W. Factors contributing to the high prevalence of multidrug-resistant tuberculosis among previously treated patients: a case–control study from China. Microb Drug Resist. 2014;20:294–300.CrossRefPubMed
26.
go back to reference Kliner M, Canaan M, Ndwandwe SZ, Busulwa F, Welfare W, Richardson M, Walley J, Wright J. Effects of financial incentives for treatment supporters on tuberculosis treatment outcomes in Swaziland: a pragmatic interventional study. Infect Dis Poverty. 2015;4:29.CrossRefPubMedPubMedCentral Kliner M, Canaan M, Ndwandwe SZ, Busulwa F, Welfare W, Richardson M, Walley J, Wright J. Effects of financial incentives for treatment supporters on tuberculosis treatment outcomes in Swaziland: a pragmatic interventional study. Infect Dis Poverty. 2015;4:29.CrossRefPubMedPubMedCentral
27.
28.
go back to reference Metcalfe JZ, Makumbirofa S, Makamure B, Sandy C, Bara W, Mungofa S, Hopewell PC, Mason P. Drug-resistant tuberculosis in high-risk groups, Zimbabwe. Emerg Infect Dis. 2014;20:135–7.CrossRefPubMedPubMedCentral Metcalfe JZ, Makumbirofa S, Makamure B, Sandy C, Bara W, Mungofa S, Hopewell PC, Mason P. Drug-resistant tuberculosis in high-risk groups, Zimbabwe. Emerg Infect Dis. 2014;20:135–7.CrossRefPubMedPubMedCentral
29.
go back to reference Sanchez-Padilla E, Dlamini T, Ascorra A, Rüsch-Gerdes S, Tefera ZD, Calain P, de la Tour R, Jochims F, Richter E, Bonnet M. High prevalence of multidrug-resistant tuberculosis, Swaziland, 2009–2010. Emerg Infect Dis. 2012;18:29–37.CrossRefPubMedPubMedCentral Sanchez-Padilla E, Dlamini T, Ascorra A, Rüsch-Gerdes S, Tefera ZD, Calain P, de la Tour R, Jochims F, Richter E, Bonnet M. High prevalence of multidrug-resistant tuberculosis, Swaziland, 2009–2010. Emerg Infect Dis. 2012;18:29–37.CrossRefPubMedPubMedCentral
30.
go back to reference Chand K, Tewari SC, Varghese SJ. Prevalence of drug resistance tuberculosis in armed forces: a study from tertiary referal chest diseases hospital at Pune. Med J Armed Forces India. 2000;56:130–4.CrossRefPubMedPubMedCentral Chand K, Tewari SC, Varghese SJ. Prevalence of drug resistance tuberculosis in armed forces: a study from tertiary referal chest diseases hospital at Pune. Med J Armed Forces India. 2000;56:130–4.CrossRefPubMedPubMedCentral
31.
go back to reference Eker B, Ortmann J, Migliori GB, Sotgiu G, Muetterlein R, Centis R, Hoffmann H, Kirsten D, Schaberg T, Ruesch-Gerdes S, Lange C. Multidrug- and extensively drug-resistant tuberculosis, Germany. Emerg Infect Dis. 2008;14:1700–6.CrossRefPubMedPubMedCentral Eker B, Ortmann J, Migliori GB, Sotgiu G, Muetterlein R, Centis R, Hoffmann H, Kirsten D, Schaberg T, Ruesch-Gerdes S, Lange C. Multidrug- and extensively drug-resistant tuberculosis, Germany. Emerg Infect Dis. 2008;14:1700–6.CrossRefPubMedPubMedCentral
32.
go back to reference Kartaloglu Z, Bozkanat E, Ozturkeri H, Okut O, IIvan A. Primuary anti-tuberculosis drug resistance at Turkish military chest disease hospital in Istanbul. Med Princ Pract. 2002;11:202–5.CrossRefPubMed Kartaloglu Z, Bozkanat E, Ozturkeri H, Okut O, IIvan A. Primuary anti-tuberculosis drug resistance at Turkish military chest disease hospital in Istanbul. Med Princ Pract. 2002;11:202–5.CrossRefPubMed
33.
go back to reference Yang Y, Zhou C, Shi L, Meng H, Yan H. Prevalence and characterization of drug-resistant tuberculosis in a local hospital of Northeast China. Int J Infect Dis. 2014;22:83–6.CrossRefPubMed Yang Y, Zhou C, Shi L, Meng H, Yan H. Prevalence and characterization of drug-resistant tuberculosis in a local hospital of Northeast China. Int J Infect Dis. 2014;22:83–6.CrossRefPubMed
34.
go back to reference Uzoewulu NG, Ibeh IN, Lawson L, Goyal M, Umenyonu N, Ofiaeli RO, Okonkwo R. Drug resistant Mycobacterium tuberculosis in tertiary hospital south east, Nigeria. J Med Microb Diagn. 2014;3:141–5. Uzoewulu NG, Ibeh IN, Lawson L, Goyal M, Umenyonu N, Ofiaeli RO, Okonkwo R. Drug resistant Mycobacterium tuberculosis in tertiary hospital south east, Nigeria. J Med Microb Diagn. 2014;3:141–5.
35.
go back to reference Zazueta-Beltran J, León-Sicairos N, Muro-Amador S, Flores-Gaxiola A, Velazquez-Roman J, Flores-Villaseñor H, Canizalez-Roman A. Increasing drug resistance of Mycobacterium tuberculosis in Sinaloa, Mexico, 1997–2005. Int J Infect Dis. 2011;15:272–6.CrossRef Zazueta-Beltran J, León-Sicairos N, Muro-Amador S, Flores-Gaxiola A, Velazquez-Roman J, Flores-Villaseñor H, Canizalez-Roman A. Increasing drug resistance of Mycobacterium tuberculosis in Sinaloa, Mexico, 1997–2005. Int J Infect Dis. 2011;15:272–6.CrossRef
36.
go back to reference Mdivani N, Zangaladze E, Volkova N, Kourbatova E, Thea Jibuti T, Shubladze N, Kutateladze T, Khechinashvili G, del Rio C, Salakaia A, Blumberg HM. High prevalence of multidrug-resistant tuberculosis in Georgia. Int J Infect Dis. 2008;12:635–44.CrossRefPubMedPubMedCentral Mdivani N, Zangaladze E, Volkova N, Kourbatova E, Thea Jibuti T, Shubladze N, Kutateladze T, Khechinashvili G, del Rio C, Salakaia A, Blumberg HM. High prevalence of multidrug-resistant tuberculosis in Georgia. Int J Infect Dis. 2008;12:635–44.CrossRefPubMedPubMedCentral
37.
go back to reference Abdul-Aziz AA, Elhassan MM, Abdulsalam SA, Mohammed EO, Hamid ME. Multi-drug resistance tuberculosis (MDR-TB) in Kassala state, eastern Sudan. Trop Dr. 2013;43:66–70. Abdul-Aziz AA, Elhassan MM, Abdulsalam SA, Mohammed EO, Hamid ME. Multi-drug resistance tuberculosis (MDR-TB) in Kassala state, eastern Sudan. Trop Dr. 2013;43:66–70.
38.
go back to reference Ruddy M, Balabanova Y, Graham C, Fedorin I, Malomanova N, Elisarova E, Kuznetznov S, Gusarova G, Zakharova S, Melentyev A, Krukova E, Golishevskaya V, Erokhin V, Dorozhkova I, Drobniewski F. Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara region, Russia. Thorax. 2005;60:130–5.CrossRefPubMedPubMedCentral Ruddy M, Balabanova Y, Graham C, Fedorin I, Malomanova N, Elisarova E, Kuznetznov S, Gusarova G, Zakharova S, Melentyev A, Krukova E, Golishevskaya V, Erokhin V, Dorozhkova I, Drobniewski F. Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara region, Russia. Thorax. 2005;60:130–5.CrossRefPubMedPubMedCentral
Metadata
Title
Risk factors associated with multidrug-resistant tuberculosis (MDR-TB) in a tertiary armed force referral and teaching hospital, Ethiopia
Authors
Biresaw Demile
Amare Zenebu
Haile Shewaye
Siqing Xia
Awoke Guadie
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2018
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-018-3167-9

Other articles of this Issue 1/2018

BMC Infectious Diseases 1/2018 Go to the issue